GALT Market Cap & Key Metrics
Galectin Therapeutics Inc.
$3.71
+$0.07(+1.92%)
42
Overall
40
Value
60
Tech
26
Quality
Market Cap
$367.90M
Volume
119.18K
52W Range
$2.03 - $7.13
Target Price
$11.00
GALT market cap is $367.90M. This page lists Galectin Therapeutics Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
GALT Key Metrics
- Market cap
- $367.90M
- EPS estimate, current year
- $-0.30
- EPS growth, 3-year
- +9.61%
- Value score
- 40
- Quality score
- 26
- Technical score
- 60
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| EBITDA | -$23.45M | -$41.47M | -$41.03M | -$37.71M | -$30.00M |
| EPS | $-0.48 | $-0.76 | $-0.74 | $-0.65 | $-0.52 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GALT | $3.71 | +1.9% | 119.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Galectin Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW